Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 37.27% is 34% above its 5-year average of 27.75%, around the middle of its 5-year range (13.55%–50.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.60% below its 12-month average of 37.49%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.27%.
DEBT TO ASSETS RATIO
37.27%
DEBT TO ASSETS RATIO AVG TTM
37.49%
DEBT TO ASSETS RATIO AVG 3Y
31.80%
DEBT TO ASSETS RATIO AVG 5Y
27.75%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.60%
CURRENT VS 3Y AVG
+17.18%
CURRENT VS 5Y AVG
+34.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+41305.72%
vs the sector median at left
Kodiak Sciences Inc.
Market Cap
$5.78B
Debt to Assets Ratio
37.27%
TTM Avg
37.49%
3Y Avg
31.80%
5Y Avg
27.75%
Market Cap
$5.79B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.87B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.95B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.52B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.23B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | $5.78B | 37.27% | 37.49% | 31.80% | 27.75% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | 0.05% | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 0.01% | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $5.89B | 0.03% | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.61B | 0.01% | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 0.52% | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | 0.52% | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 0.01% | N/A | N/A | N/A |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.23B | 0.01% | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 0.21% | N/A | N/A | N/A |
Debt/Assets
37.3%
Debt/Equity
1.57
Current Ratio
2.49
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 37.27% |
| 2026-03-31 | 50.98% |
| 2025-12-31 | 45.28% |
| 2025-09-30 | 28.52% |
| 2025-06-30 | 25.40% |
| 2025-03-31 | 22.70% |
| 2024-12-31 | 20.96% |
| 2024-09-30 | 19.71% |
| 2024-06-30 | 18.86% |
| 2024-03-31 | 41.02% |
| 2023-12-31 | 37.89% |
| 2023-09-30 | 33.50% |
| 2023-06-30 | 31.34% |
| 2023-03-31 | 13.55% |
| 2022-12-31 | 28.16% |
| 2022-09-30 | 25.94% |
| 2022-06-30 | 23.92% |
| 2022-03-31 | 21.33% |
| 2021-12-31 | 19.90% |
| 2021-09-30 | 18.67% |
| 2021-06-30 | 17.86% |
| 2021-03-31 | 7.52% |
| 2020-12-31 | 7.25% |
| 2020-09-30 | 16.08% |
| 2020-06-30 | 0.40% |
| 2020-03-31 | 0.41% |
| 2019-12-31 | 0.54% |
| 2019-09-30 | 2.96% |
| 2019-06-30 | 2.73% |
| 2019-03-31 | 2.61% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 242.34% |
| 2018-06-30 | 0.49% |
| 2017-12-31 | 310.79% |
